A new study published in Becker's Healthcare is putting consolidated ASC pricing dynamics back in the spotlight - finding that consolidation and vertical integration are reshaping how prices flow through the system. Regardless of ownership model, the implications are the same: ASC leaders need better visibility into what they're paying, what they're charging, and where the gaps are. Whether you're an independent ASC, part of a health system, or operating within a national platform - the ability to see, benchmark, and manage implant and biologic spend at a granular level has never been more critical. At AlloDirect, we partner with ASCs across the spectrum to deliver: ✅ Real-time visibility across vendors and facilities ✅ Benchmarking tools that support smarter negotiations with payers and suppliers ✅ A platform built to drive value for every stakeholder... Patients, Administrators, and Surgeons Consolidation isn't slowing down. The organizations that invest in pricing transparency and supply chain intelligence will be best positioned - no matter their ownership structure. Curious how AlloDirect can support your ASC strategy? Let's connect. AMSURG Ascension Ventures Ascension Abundant Venture Partners MTF Biologics OrthoCarolina Orthopedic ONE Cleveland Clinic Orthopaedic Surgery & Sports Medicine Orthopedic Center of Excellence at Denver Health SCA Health United Surgical Partners International, Inc Vizient, Inc Vizient Southeast Vizient Southern States, Inc. Indiana Orthopedic Institute OrthoIndy Tristate Orthopedics Center Indianapolis Business Journal Ambulatory Surgery Center Association (ASCA) Illinois Ambulatory Surgery Center Association Michigan Ambulatory Surgery Association Franciscan Alliance, Inc. HealthTrust Performance Group Lakeshore Bone & Joint Institute Full coverage from Becker's: https://lnkd.in/guThtdFj
